ArticleScientific reports2026
Improving rectal tumor segmentation with anomaly fusion derived from anatomical inpainting: a multicenter study.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Accurate rectal tumor segmentation using magnetic resonance imaging (MRI) is paramount for effective treatment planning. It allows for volumetric and other quantitative tumor assessments, potentially aiding in prognostication and treatment response evaluation. Manual delineation of rectal tumors and surrounding structures is time-consuming and labor-intensive. Over the past few years, deep learning has shown strong results in automated tumor segmentation in MRI. Current studies on automated rectal tumor segmentation, however, focus solely on tumoral regions without considering the rectal anatomical entities and often lack a solid multicenter external validation. In this study, we improved rectal tumor segmentation by incorporating anomaly maps derived from anatomical inpainting. This inpainting was trained using a U-Net-based model and trained to reconstruct a healthy rectum and mesorectum from prostate T2-weighted images (T2WI). The rectal anomaly maps were generated from the difference between the original rectal and reconstructed pseudo-healthy slices. The derived anomaly maps were used in the downstream tumor segmentation tasks by fusing them as an additional input channel (AAnnUNet). Alternative methods for integrating rectal anatomical knowledge were evaluated as baselines, including Multi-Target nnUNet (MTnnUNet), which added rectum and mesorectum segmentation as auxiliary tasks, and Multi-Channel nnUNet (MCnnUNet), which utilized rectum and mesorectum masks as additional input channels. As part of this study, we benchmarked nine models for rectal tumor segmentation on a large multicenter (num = 705) dataset of preoperative T2WI and nnUNet outperformed the other eight models on the external test. The MTnnUNet demonstrated improvements in both fully-supervised and mixed-supervised settings where human-annoated tumor masks and AI-generated rectum and mesoretum masks were used compared to nnUNet, while the MCnnUNet showed benefits only in the setting where mixed-supervision were used. Importantly, anomaly maps were strongly associated with tumoral regions, and their integration within AAnnUNet led to the best tumor segmentation results across both settings. The effectiveness of AAnnUNet demonstrated the value of the anomaly maps, indicating a promising direction for improving rectal tumor segmentation and model robustness for multicenter data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.